IMR Press / FBL / Volume 9 / Issue 1 / DOI: 10.2741/1268

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Nitric oxide neurotoxicity in neurodegenerative diseases
Show Less
1 Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260, USA
Front. Biosci. (Landmark Ed) 2004, 9(1), 763–776; https://doi.org/10.2741/1268
Published: 1 January 2004
Abstract

Nitric oxide (nitrogen monoxide; NO) is a simple molecule with diverse biological functions. NO and related reactive nitrogen oxide species (RNOS) mediate intricate physiological and pathophysiological effects in the central nervous system. Depending on environmental conditions, NO and RNOS can initiate and mediate neuroprotection or neurotoxicity either exclusively or synergistically with other effectors. The focus of this review is limited to the neuroprotectant/neurotoxic role of NO in Acquired Immune Deficiency Syndrome (AIDS) Dementia Complex (aka HIV—Associated Dementia; HAD) Amyotrophic Lateral Sclerosis (aka Lou Gehrig's Disease), Alzheimer's Disease, Huntington's Disease, Multiple Sclerosis and Parkinson's Disease. This review will shed light on the question: "How important is NO in neurodegenerative diseases?"

Keywords
Nitric Oxide
Blood Brain Barrier
Neuroinflammation
Neurodegenerative Diseases
Acquired Immune Deficiency Syndrome (AIDS) Dementia Complex
HIV-Associated Dementia
Amyotrophic Lateral Sclerosis
Alzheimer's Disease
Huntington’s Disease
Multiple Sclerosis
Parkinson’s Disease
Review
Share
Back to top